Medical Device made Easy Podcast Podcast By easymedicaldevice cover art

Medical Device made Easy Podcast

Medical Device made Easy Podcast

By: easymedicaldevice
Listen for free

Prime Member Exclusive | $0.99/mo for 4 months

$8.99/mo thereafter—terms apply.

My name is Monir El Azzouzi and I am a Medical Device Expert specialized in Quality and Regulatory affairs. And on this podcast I will help you place compliant medical devices on the market. For that I will share with you my knowledge or the one of others through discussion or interviews. I will invite experts in the area to tell you what you can do or the challenges you may encounter.

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Monir El Azzouzi Economics Leadership Management & Leadership
Episodes
  • Your Technical Documentation Has All the Documents… So Why Isn't It Ready?

    Your Technical Documentation Has All the Documents… So Why Isn't It Ready?
    Sep 10 2026
    A company says its Medical Device Technical Documentation is 90% or 95% ready.The Risk Management File exists. The Clinical Evaluation is complete. Testing has been performed. The GSPR checklist and IFU are available.But there's an important question:95% of what?Having all the expected documents doesn't necessarily mean your Technical Documentation is ready for assessment. Like a puzzle, you can have every piece on the table—but if some pieces are outdated, others belong to a different version of the product, and several don't fit together, the puzzle isn't complete.1. Start With the Product, Not Annex IIInstead of immediately opening an Annex II template and looking for documents to fill each section, start with a more fundamental question:What exactly are we trying to certify?Your intended purpose, patient population, intended users, use environment, indications, contraindications, lifetime, claims, variants and accessories should provide a common source of truth across the Technical Documentation.If Marketing makes a claim that isn't reflected in the intended purpose, Clinical Evaluation or Risk Management File, you may already have a significant consistency problem.2. Challenge Your Regulatory Assumptions“It's Class IIa because our competitor is Class IIa” isn't a classification rationale.Early assumptions about qualification, classification and conformity assessment can influence testing, clinical strategy, budget and Notified Body involvement.Those assumptions should therefore be challenged and properly documented before they become expensive to change.3. Use the GSPR to Build the DossierThe GSPR shouldn't simply appear at the end of the project as another checklist.For every applicable requirement, ask:How will we demonstrate conformity?That means identifying the relevant standard, specification, analysis, test or report—and determining whether the required evidence actually exists.Used this way, the GSPR becomes a tool for building Technical Documentation and identifying evidence gaps early.4. Available Doesn't Mean AdequateOne of the biggest mistakes in Technical Documentation gap assessments is asking only:“Do we have this document?”A better question is:“Is this evidence adequate for the device we're certifying?”A biocompatibility report may exist—but does it cover the same materials, manufacturing process, patient-contacting components and contact duration?Software verification may exist—but does it cover the current software version?Clinical evidence may exist—but does it support the current intended purpose and claims?That's why Available, Applicable and Adequate are three different things.5. Make Sure the Puzzle FitsBefore submission, consistency and traceability become critical.Imagine the IFU says the device can be used for seven days, while the Risk Management File and biological evaluation assume only 24 hours.Every document exists—but together they don't tell a coherent story.A reviewer should be able to trace important claims through intended purpose, design requirements, verification, clinical evidence, risk management, labeling and PMS.Likewise, important risks should connect logically to risk controls, design implementation, verification, residual risk and post-market monitoring.The 80/20 Approach to Technical DocumentationInstead of focusing first on the number of documents completed, focus on five questions:Do we understand the product and its claims?Is our regulatory strategy defensible?Have requirements been translated into evidence needs?Is our evidence adequate?Does everything tell the same story?Strong foundations make the rest of Technical Documentation much easier to structure.EMD Technical Documentation RoadmapTo support this process, Easy Medical Device created the EMD Technical Documentation Roadmap.The tool provides a structure for understanding the product, documenting regulatory strategy, mapping requirements, identifying standards and guidance, connecting risks with evidence, assessing gaps, assigning responsibilities, performing consistency checks, and ultimately mapping the documentation into Annex II and Annex III.Final TakeawayStop thinking about Technical Documentation as a collection of folders that need to be filled.Think about what the reviewer needs to understand:Is there sufficient, coherent evidence demonstrating that this device conforms with the applicable requirements?Your Technical Documentation isn't a filing cabinet.Easy Medical Device ServicesCE Marking • MDR • IVDR • Technical DocumentationMedical Device Market Access Services – Easy Medical DeviceBack Office Services (BOSS Program)SmartEye eQMSSmartEye – eQMS – Easy Medical DeviceEasyIFUElectronic IFU & Label CreationEasyIFU – Easy Medical DeviceAuthorized RepresentativeEU • UK • SwitzerlandWorldwide Market AccessMarket AccessMarket Accesshttps://easymedicaldevice.com/services/market-access/embed/#?secret=qJuMYs1tqH#?secret=dFwrzZJcuHSocial Media to ...
    Show more Show less
    38 mins
  • Medical Device Regulatory Update: July & August 2026

    Medical Device Regulatory Update: July & August 2026
    Sep 2 2026
    Medical device regulation continues to evolve across multiple markets. For manufacturers, the challenge isn't simply following every new publication—it's understanding which developments require action, which ones need monitoring, and how they affect existing regulatory strategies.This latest Medical Device Made Easy regulatory update reviews selected developments from July and August 2026 across Europe, Switzerland, the UK, United States, India, Singapore, and Brazil.🇪🇺 UDI Assignment Under Distributor BrandingRead MDCG 2026-5 – UDI AssignmentMDCG 2026-5 addresses situations where the same medical device is sold under both the manufacturer's brand and a distributor's brand.Different UDI-DIs may be appropriate, but when the original manufacturer remains the legal manufacturer, the codes must remain assigned by and linked to that manufacturer. This makes existing private-label arrangements, UDI structures, EUDAMED records, and agreements worth reviewing.🇪🇺 Notified Body Certification & Fee TransparencyTeam-NB MDR Certification Process v2.1European Commission Notified Body Fee DirectoryTeam-NB's updated consensus paper maps the MDR certification journey from pre-application and quotation through conformity assessment, certification, and surveillance.Combined with the European Commission's consolidated directory of Notified Body fee pages, these resources can help manufacturers better understand both the certification process and the costs that need to be considered when planning market access.🇨🇭 swissdamed Registration Becomes MandatorySwissmedic – swissdamed Registration ObligationFrom 1 July 2026, manufacturers and authorised representatives must register relevant devices, systems, and procedure packs in the swissdamed UDI Devices module.The general transition period ends on 31 December 2026, making data preparation, responsibility allocation, and reconciliation important operational priorities for companies active in Switzerland.🇬🇧 MHRA Guidance on Ambient Voice TechnologyRead the MHRA GuidanceThe MHRA provides useful clarification on when ambient voice technologies, including clinical scribes, may fall within medical device regulation.Pure transcription or clinician-reviewed administrative summaries may remain outside medical device qualification, while diagnostic insights, treatment recommendations, or medical-performance claims can create a medical intended purpose.🇺🇸 FDA FY 2027 Medical Device User FeesFDA FY 2027 Medical Device User FeesFDA published its FY 2027 medical device user fee notice, covering submission fees, establishment registration, small-business reductions, and related payment procedures.The new fee year applies from 1 October 2026 through 30 September 2027, making the actual submission receipt date an important consideration when planning budgets.🇮🇳 CDSCO Medical Device Software GuidanceRead the CDSCO Medical Device Software GuidanceIndia's CDSCO guidance covers qualification, classification, QMS, technical documentation, clinical evidence, AI-enabled software, cybersecurity, lifecycle change control, and post-market monitoring.One important message for global manufacturers is that an EU or US classification rationale shouldn't simply be reused without mapping the device and evidence to the Indian framework.🇸🇬 Singapore Updates Medical Device Cybersecurity GuidanceSingapore HSA Medical Device GuidanceSingapore HSA published an updated Best Practices Guide on Medical Device Cybersecurity in August 2026.For connected medical devices and software manufacturers, it provides another useful benchmark for secure development, vulnerability management, updates, and post-market cybersecurity activities.📅 Stay Updated on MedTech EventsExplore MedTech Conferences & Events on MedTechConfThe episode also highlights upcoming opportunities covering Article 117, MDR/IVDR, biocompatibility, AI, clinical evidence, PMS, vigilance, digital health, and African medical device regulation.🎙️ Continue Learning with Easy Medical DeviceExplore the Easy Medical Device PodcastThe July and August catalogue covers audit readiness, FDA clearance, risk management, QMS effectiveness, Intended Use, Master UDI-DI, Verification & Validation, DHF remediation, and global market access.Easy Medical Device ServicesCE Marking • MDR • IVDR • Technical DocumentationMedical Device Market Access Services – Easy Medical DeviceBack Office Services (BOSS Program)SmartEye eQMSSmartEye – eQMS – Easy Medical DeviceEasyIFUElectronic IFU & Label CreationEasyIFU – Easy Medical DeviceAuthorized RepresentativeEU • UK • SwitzerlandWorldwide Market AccessMarket Accesshttps://easymedicaldevice.com/services/market-access/embed/#?secret=LwbhU8XuNP#?secret=MqJ5tTiYnQSocial Media to followMonir El Azzouzi Linkedin: https://linkedin.com/in/melazzouziTwitter: https://twitter.com/elazzouzimPinterest: https://www.pinterest.com/easymedicaldeviceInstagram: https://...
    Show more Show less
    44 mins
  • From Verification & Validation to Global Market Access | V&V, DHF & IMDRF

    From Verification & Validation to Global Market Access | V&V, DHF & IMDRF
    Aug 27 2026
    Developing a medical device successfully requires several pieces to work together. Manufacturers must demonstrate that the product meets its requirements, maintain reliable design documentation, and understand how regulatory expectations differ—or increasingly align—across global markets.In this Easy Medical Device podcast collection, we explore three connected topics that represent different stages of this journey: Verification & Validation, Design History File remediation, and IMDRF and regulatory reliance.Making Verification & Validation PracticalVerification and Validation are fundamental parts of medical device development, but the distinction between them can sometimes create confusion.Verification focuses on whether the device has been developed according to defined requirements, while validation considers whether the resulting device meets its intended use and user needs.Understanding how to plan and execute V&V effectively helps manufacturers build stronger evidence around device performance and supports a more structured development process.When Your Design History File Needs RemediationWhat happens when the product has already been developed, but the Design History File doesn't properly demonstrate the development journey?DHF remediation can become necessary when documentation is incomplete, fragmented, poorly traceable, or does not adequately demonstrate how design controls were applied.The discussion explores the importance of rebuilding those connections and creating documentation that clearly demonstrates the relationship between requirements, design activities, V&V evidence, risk management, and design decisions.The objective isn't simply to create more documentation. It's to create a coherent and traceable design history.IMDRF, Regulatory Reliance and Global Market AccessOnce a device is ready for market, manufacturers face another challenge: navigating multiple regulatory systems around the world.The International Medical Device Regulators Forum (IMDRF) plays an important role in encouraging greater regulatory convergence internationally.Regulatory reliance takes this concept further by allowing authorities, where applicable, to leverage assessments or decisions from other trusted regulatory authorities rather than unnecessarily duplicating the entire review process.For manufacturers seeking international expansion, understanding these developments can become an important part of building an efficient global market access strategy.Connecting the Entire JourneyThese three topics may appear separate, but they represent a logical progression:Verification & Validation → Design Documentation → Global Regulatory ApprovalsFirst, manufacturers need evidence that the device performs as expected.Then, they need documentation that clearly demonstrates how the device was developed and controlled.Finally, they need a regulatory strategy capable of bringing that device into different markets.For MedTech companies, getting these elements right can create a stronger foundation for compliance, regulatory submissions, and international market access.A successful regulatory journey doesn't begin with the submission—it begins with how the device is designed, tested, documented, and prepared for the markets it intends to enter.Who is Monir El Azzouzi? Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.Social Media to followMonir El Azzouzi Linkedin: https://linkedin.com/in/melazzouziTwitter: https://twitter.com/elazzouzimPinterest: https://www.pinterest.com/easymedicaldeviceInstagram: https://www.instagram.com/easymedicaldeviceThis podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
    Show more Show less
    32 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet